121 related articles for article (PubMed ID: 11588555)
21. Chronic hepatitis C and normal ALT: considerations for treatment.
Bacon BR
Am J Gastroenterol; 2004 Sep; 99(9):1706-7. PubMed ID: 15330906
[TBL] [Abstract][Full Text] [Related]
22. Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.
von Wagner M; Huber M; Berg T; Hinrichsen H; Rasenack J; Heintges T; Bergk A; Bernsmeier C; Häussinger D; Herrmann E; Zeuzem S
Gastroenterology; 2005 Aug; 129(2):522-7. PubMed ID: 16083709
[TBL] [Abstract][Full Text] [Related]
23. [Due to normal transaminase values, no further treatment. Hepatitis C patient "suddenly" has liver cirrhosis].
MMW Fortschr Med; 2004 May; 146(19):64. PubMed ID: 15357490
[No Abstract] [Full Text] [Related]
24. A particular hepatitis C virus protease NS3 gene pattern in a patient not responding to interferon-ribavirin therapy.
Vallet S; Nousbaum JB; Gouriou S; Legrand-Quillien MC; Goudeau A; Picard B
Eur J Clin Microbiol Infect Dis; 2005 Jan; 24(1):79-80. PubMed ID: 15616841
[No Abstract] [Full Text] [Related]
25. Combination treatment of IFNalpha2b and ribavirin in patients with chronic hepatitis C and persistently normal ALTs.
Erhardt A; Behlen-Wilm U; Adams O; Donner A; Heintges T; Häussinger D
Dig Dis Sci; 2003 May; 48(5):921-5. PubMed ID: 12772791
[TBL] [Abstract][Full Text] [Related]
26. Hepatic granulomas of unknown cause presenting with fever.
Terplan M
Am J Gastroenterol; 1971 Jan; 55(1):43-9. PubMed ID: 5550744
[No Abstract] [Full Text] [Related]
27. The prevalence of hepatic granulomas in chronic hepatitis C.
Ozaras R; Tahan V; Mert A; Uraz S; Kanat M; Tabak F; Avsar E; Ozbay G; Celikel CA; Tozun N; Senturk H
J Clin Gastroenterol; 2004; 38(5):449-52. PubMed ID: 15100526
[TBL] [Abstract][Full Text] [Related]
28. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
[TBL] [Abstract][Full Text] [Related]
29. Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
de Lédinghen V; Trimoulet P; Winnock M; Foucher J; Bourlière M; Desmorat H; Canva V; Capron D; Lévy S; Mion F; Mannant PR; Chêne G; Fleury H; Couzigou P; Bernard PH;
J Hepatol; 2002 May; 36(5):672-80. PubMed ID: 11983451
[TBL] [Abstract][Full Text] [Related]
30. Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C.
Jung CH; Um SH; Kim TH; Yim SY; Suh SJ; Yim HJ; Seo YS; Choi HS; Chun HJ
Gut Liver; 2016 Sep; 10(5):808-17. PubMed ID: 27114417
[TBL] [Abstract][Full Text] [Related]
31. Granulomatous hepatitis.
Fauci AS; Wolff SM
Prog Liver Dis; 1976; 5():609-21. PubMed ID: 775558
[No Abstract] [Full Text] [Related]
32. [Treatment of patients with chronic hepatitis C who never had been treated].
Hézode C
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B38-49. PubMed ID: 12180307
[No Abstract] [Full Text] [Related]
33. Pegylated interferon alpha-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases.
Iacob S; Gheorghe L; Hrehoret D; Becheanu G; Herlea V; Popescu I
J Gastrointestin Liver Dis; 2008 Jun; 17(2):165-72. PubMed ID: 18568137
[TBL] [Abstract][Full Text] [Related]
34. Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection.
Loustaud-Ratti V; Liozon E; Karaaslan H; Alain S; Paraf F; Le Meur Y; Denis F; Vidal E
Am J Med; 2002 Oct; 113(6):516-9. PubMed ID: 12427502
[No Abstract] [Full Text] [Related]
35. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
Nadeem A; Hussain MM; Aslam M; Hussain T; Butt IF; Ali Khan S; Asad A
J Ayub Med Coll Abbottabad; 2009; 21(2):103-6. PubMed ID: 20524482
[TBL] [Abstract][Full Text] [Related]
36. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
[TBL] [Abstract][Full Text] [Related]
37. Toll like receptor 3 expression as a novel predictor of response to treatment in chronic hepatitis C virus patients.
Hashad DI; Salem PE; Abdallah DM
Scand J Clin Lab Invest; 2011 Dec; 71(8):641-6. PubMed ID: 22023039
[TBL] [Abstract][Full Text] [Related]
38. Hemoglobinuria with ribavirin treatment.
Massoud OI; Yousef WI; Mullen KD
J Clin Gastroenterol; 2003 Apr; 36(4):367-8. PubMed ID: 12642748
[TBL] [Abstract][Full Text] [Related]
39. Interferon-alpha-2b + ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-alpha-monotherapy.
Tromm A; Greving I; Griga T; Mankel K; Hüppe D
Z Gastroenterol; 2000 Feb; 38(2):159-64. PubMed ID: 10721171
[TBL] [Abstract][Full Text] [Related]
40. A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy.
Saracco G; Olivero A; Ciancio A; Carenzi S; Smedile A; Cariti G; Andreoni M; Orsi PG; Biglino A; Tabone M; Roffi L; Croce G; Manca A; Tappero G; Ciccone G; Rizzetto M
Hepatology; 2002 Oct; 36(4 Pt 1):959-66. PubMed ID: 12297844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
